Merck & Company, Inc. vs Zoetis Inc. — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
ZTS
Zoetis Inc.
$114.16
▼ 0.70%
Q·Score Winner
Zoetis Inc.
ZTS7.5/10vs 6.7/10

Q·Score Breakdown

6.7
Neutral
Overall
7.5
Bullish
6.2
Quality
9.3
7
Health
6.7
6.2
Growth
5.7
7.2
Valuation
8.6
7.1
Sentiment
6.5
MRK

Forward P/E of 11.5× is low relative to sector peers.

ZTS

High-quality business with 66% return on equity and 28% profit margins.

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $148.88 (+30.4%)
17 analysts

Fundamentals

MRK
ZTS
31.5×
Trailing P/E
19.0×
11.5×
Forward P/E
15.1×
13.6%
Profit Margin
28.2%
76.6%
Gross Margin
71.9%
ROE
66.0%
4.9%
Revenue Growth
3.0%
Earnings Growth
6.1%
0.28
Beta
0.97
Price / Book
$277.0B
Market Cap
$48.2B
$73 – $125
52-Week Range
$113 – $172

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →